How to Buy Connect Biopharma Holdings Stock

Connect Biopharma Holdings Ltd

Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation.

Connect Biopharma Holdings stock last closed at $0.74, down 10.96% from the previous day, and has decreased 52.32% in one year. It has overperformed other stocks in the Biotechnology industry by 0.26 percentage points. Connect Biopharma Holdings stock is currently +44.9% from its 52-week low of $0.51, and -64.47% from its 52-week high of $2.08.

At the moment, there are 55.35M CNTB shares outstanding. The market capitalization of CNTB is $40.90M. In the last 24 hours, 103,779 CNTB shares were traded.

How to Buy Connect Biopharma Holdings Stock

Not sure how to invest in Connect Biopharma Holdings stock? Here's how.

  1. Figure out where to buy Connect Biopharma Holdings stock: You need to decide on a stock brokerage, but don't worry - we've researched dozens of online brokerages and apps to help you choose where to buy Connect Biopharma Holdings stock.
  2. Sign up for a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
  3. Fund your brokerage account: Choose your payment method and add your details.
  4. Research Connect Biopharma Holdings stock: The Connect Biopharma Holdings ticker symbol is CNTB. Is Connect Biopharma Holdings stock a good investment? Should you buy shares of CNTB? How do CNTB's underlying business fundamentals look? Do top analysts think Connect Biopharma Holdings is a good buy? Why has CNTB's stock price moved recently? (Hint: Our stock research tools can help you figure out if CNTB is a good stock to buy).
  5. Place your CNTB purchase: Decide if you will purchase CNTB shares at the current market price or use a limit order to purchase CNTB shares at a given price.
  6. Monitor your CNTB position: Create a watchlist to keep tabs on your new investment in Connect Biopharma Holdings stock.

Step 1: Figure out where to buy Connect Biopharma Holdings stock

You need a brokerage account to access the NASDAQ market and buy CNTB stock.

A brokerage account enables you to buy and sell a number of investments, including stocks, bonds, mutual funds, and ETFs.

Our favorite brokerage: eToro

We believe that eToro is the best brokerage. Here's why:

  • You can invest in stocks with 0% commissions: Invest without paying trading commissions.
  • Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
  • Access to world markets: From Tech to Healthcare, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading exchanges.
  • Social investing: eToro offers a community of more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of top investors.
  • Security: eToro is a regulated and licensed brokerage platform.
  • Buy other financial assets: Such as ETFs and cryptocurrencies.

Get $10 towards your purchase of stock by opening an account with eToro now. This offer is only for US users.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Sign up for a brokerage account

Now that you've chosen the best brokerage, you need to fill out some personal information so you are able to invest in CNTB today.

How to Set Up a New Investment Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Input your personal details to open a new trading account.
  1. Submit your data by clicking the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Fund your brokerage account

Now that you have opened your account on stock market apps, you can securely and quickly fund your account:

Watch the walkthrough below if you need help depositing funds into your new brokerage account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Research Connect Biopharma Holdings stock

After you have figured out the best place to buy Connect Biopharma Holdings stock, it's critical to analyze their stock before you buy, so you truly comprehend the risk as well as the upside.

Connect Biopharma Holdings shares at a glance

CNTB Price
$0.74
1w %
15.65%
1y %
-52.32%
5y %
N/A
P/E
-2.64x
P/B
0.44x
P/S
1.57x
PEG
N/A
Revenue
$26.03M
Earnings
-$15.63M
Fore. Rev. Growth
11.15%
Fore. Earn. Growth
N/A
Market Cap
$40.90M
Next Earnings
N/A
Next Dividend
N/A

CNTB Due Diligence Checks

WallStreetZen was built to help part-time investors perform more accurate fundamental analysis.

You can see all of the due diligence checks on CNTB's stock page.

Is CNTB stock overvalued?

Investors use many financial metrics, analyses, models, and charts to gauge CNTB's true value.

Using relative valuations metrics:

  • CNTB could be undervalued based on its P/B ratio of 0.44x, relative to Biotechnology industry P/B ratio of 4.05x

You can do more valuation research on CNTB's stock here.

CNTB Financial Summary

Signs that CNTB is financially healthy:

  • CNTB has a low debt to equity ratio of 0.1.
  • Total CNTB debt is lower than 5 years ago, relative to shareholder equity.
  • CNTB has $93.71M in cash and short term investments. This is sufficient to cover its annual cash burn of $24.36M.
  • There are more short-term assets than long-term liabilities on the CNTB balance sheet.
  • CNTB has cash burn of 24362000. It has sufficient cash and short-term investments to cover this for at least one year.
  • There are more short-term assets than short-term liabilities on the CNTB balance sheet.

Signs that CNTB is not financially healthy:

  • CNTB profit margin has gone down from N/A to -60% in the past year.

Is CNTB stock a Buy, Hold, or Sell, according to analysts?

Out of 1 Wall Street analysts who give forecasts on CNTB, the consensus analyst rating on Connect Biopharma Holdings is a Buy

Please note that analyst forecasts are not recommendations, nor are they investment advice.

You can dig deeper into what analysts are forecasting on the Connect Biopharma Holdings stock forecast page.

CNTB Trading Indicators

SMA10
0.68
SMA20
0.69
SMA50
0.8
SMA100
0.93
SMA200
1.07
MACD
-0.02
MACD Signal
-0.05
MACD Histogram
0.03
RSI
50.81
Stochastic %K
59.12
Stochastic %D
54.68
StochRSI %K
91.98
StochRSI %D
95.14

Latest Insiders Trades at CNTB

Over the last year, executives and large shareholders at CNTB have not bought or sold any shares.

Research more about who owns CNTB stock here.

Does CNTB provide a stable income stream?

No, Connect Biopharma Holdings doesn't provide an income stream by paying out dividends.

What others are saying about CNTB

One of the major reasons eToro is our favorite brokerage is because of its social trading community.

Click below to learn what other traders have to say.

Step 5: Place your CNTB purchase

There are two main types of orders:

  • Market order: A market order is an order to buy or sell a security at the best possible price.
    Market orders are mostly fine.
  • Limit order: A limit order is an order to buy or sell a security at a specific price (or better).
    If you want to be sure you're buying or selling at an exact price, use a limit order.

Press the Open button and your broker will place your order.

If you need additional help with buying stocks on eToro, click the helpful video below:

Open eToro Account

Step 6: Monitor your CNTB position

Now that you own some shares in CNTB, you'll want to stay up-to-date on your investment.

Start a watchlist to monitor your CNTB stock.

CNTB Feed

How to Buy Stock in Connect Biopharma Holdings

To summarize, here are the 6 steps you need to take to buy Connect Biopharma Holdings stock right now:

  1. Figure out where to buy Connect Biopharma Holdings stock
  2. Sign up for a brokerage account
  3. Fund your brokerage account
  4. Research Connect Biopharma Holdings stock
  5. Place your CNTB purchase
  6. Monitor your CNTB position

If you require a online brokerage, eToro is our recommended venue.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you want to keep track of your new investment in Connect Biopharma Holdings, create a watchlist on WallStreetZen today.

NASDAQ: CNTB
$0.74-0.09 (-10.96%)
Updated Apr 17, 2025
Open eToro Account
Your capital is at risk.
NASDAQ: CNTB
$0.74-0.09 (-10.96%)
Updated Apr 17, 2025
Open eToro Account
Your capital is at risk.

FAQ

How much does it cost to buy one Connect Biopharma Holdings share?

As of Apr 17, 2025, it costs $0.74 to buy one share of Connect Biopharma Holdings stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $0.37, you can buy 0.5 shares of CNTB.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Connect Biopharma Holdings stock?

According to 1 Wall Street analysts who monitor Connect Biopharma Holdings, their consensus recommendation is to buy Connect Biopharma Holdings stock.

What is the best way to buy Connect Biopharma Holdings stock?

One way to place an order for Connect Biopharma Holdings stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.